# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-124918
Filing Date
2021-10-12
Accepted
2021-10-12 06:15:58
Documents
6
Period of Report
2021-11-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2129289d1_def14a.htm | DEF 14A | 270224
2 | GRAPHIC | tm2129289d1_def14aimg01.jpg | GRAPHIC | 3597
3 | GRAPHIC | image_002.jpg | GRAPHIC | 127354
4 | GRAPHIC | image_003.jpg | GRAPHIC | 112383
5 | GRAPHIC | image_004.jpg | GRAPHIC | 156608
6 | GRAPHIC | image_005.jpg | GRAPHIC | 282784
| Complete submission text file | 0001104659-21-124918.txt |  | 1212327

Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36081 | Film No.: 211316712
SIC: 2834 Pharmaceutical Preparations